Smartphone messages may boost medication adherence after liver transplant

NCT ID NCT07728604

Completed Disease control Sponsor: Cansu Yıldız Source: ClinicalTrials.gov ↗

First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time

Summary

This trial tests whether sending structured digital follow-up messages to liver transplant patients for 12 weeks can help them take their immunosuppressive medication as prescribed and improve their quality of life. Half of the participants receive standard discharge education plus digital messages, while the other half receive standard care alone. Medication adherence and quality of life are measured before and after the intervention using validated questionnaires.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: digital follow-up supported patient education (structured digital messages via smartphone)
What this could lead to: If it works, this could point toward a simple, low-cost way to help liver transplant patients stay on their medication and feel better.
What could go wrong: This is a small, early-stage trial with only 48 participants, so results may not apply to everyone. The benefit of digital messages over standard care may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER TRANSPLANTATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Medication Adherence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LIVER TRANSPLANTATION MEDICATION ADHERENCE

Contacts and locations

Locations

Acibadem İzmir Kent Hospital

Izmir, 35620, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.